Bruce Lessey to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Bruce Lessey has written about Dose-Response Relationship, Drug.
Connection Strength
0.062
-
Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. N Engl J Med. 2017 07 06; 377(1):28-40.
Score: 0.033
-
Usadi RS, Groll JM, Lessey BA, Lininger RA, Zaino RJ, Fritz MA, Young SL. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab. 2008 Oct; 93(10):4058-64.
Score: 0.018
-
Young SL, Lessey BA, Fritz MA, Meyer WR, Murray MJ, Speckman PL, Nowicki BJ. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab. 2002 Mar; 87(3):1368-75.
Score: 0.012